DTIL
PRECISION BIOSCIENCES INC
NASDAQ · Healthcare · Biotechnology · US
$7.95
+14.06%Margins
Gross margin
100.0%
EBITDA margin
-108.4%
EBIT margin
-80.3%
Net margin
-85.6%
FCF margin
-115.0%
-74.4%
Return on equity
-32.0%
Return on assets
-67.7%
Return on invested capital
0.37x
Asset turnover
-$51.8M
Cash from operations
$2.93
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026